Market Closed -
Nasdaq
16:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
1.56
USD
|
-4.29%
|
|
0.00%
|
-78.78%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
425.6
|
128.1
|
215.1
|
48.33
|
-
|
-
|
Enterprise Value (EV)
1 |
276.4
|
27.38
|
134.2
|
-9.432
|
-24.46
|
-56.6
|
P/E ratio
|
-6.57
x
|
-2.54
x
|
-3.91
x
|
-0.73
x
|
-0.74
x
|
-0.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
205
x
|
404
x
|
-
|
-
|
-
|
-
|
EV / Revenue
|
133
x
|
86.4
x
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-8.17
x
|
-0.53
x
|
-2.31
x
|
0.13
x
|
0.29
x
|
0.59
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.41
x
|
1.17
x
|
2.38
x
|
0.77
x
|
0.83
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
26,320
|
26,405
|
29,269
|
29,653
|
-
|
-
|
Reference price
2 |
16.17
|
4.850
|
7.350
|
1.560
|
1.560
|
1.560
|
Announcement Date
|
22-03-10
|
23-03-06
|
24-03-01
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
2.08
|
0.317
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-33.84
|
-51.47
|
-58.09
|
-72.18
|
-84.76
|
-96.03
|
EBIT
1 |
-
|
-33.89
|
-51.74
|
-58.41
|
-75.58
|
-96.82
|
-115.4
|
Operating Margin
|
-
|
-1,629.17%
|
-16,325.88%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-33.84
|
-50.51
|
-53.47
|
-73.43
|
-100.8
|
-122.1
|
Net income
1 |
-17.04
|
-33.54
|
-50.51
|
-53.47
|
-72.68
|
-97.5
|
-117.6
|
Net margin
|
-
|
-1,612.33%
|
-15,937.39%
|
-
|
-
|
-
|
-
|
EPS
2 |
-4.820
|
-2.460
|
-1.910
|
-1.880
|
-2.145
|
-2.095
|
-2.238
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-05-13
|
22-03-10
|
23-03-06
|
24-03-01
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.1896
|
0.1837
|
0.0944
|
0.0384
|
0.00046
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-11.12
|
-12.93
|
-11.65
|
-13.19
|
-13.99
|
-14.68
|
-13.5
|
-13.93
|
-16.3
|
-15.33
|
-18.38
|
-20.05
|
-22.43
|
-23.31
|
-25.41
|
Operating Margin
|
-5,863.05%
|
-7,036.29%
|
-12,334.3%
|
-34,362.04%
|
-3,040,219.57%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-11.09
|
-12.9
|
-11.53
|
-12.84
|
-13.25
|
-13.6
|
-12.19
|
-12.6
|
-15.08
|
-14.31
|
-17.63
|
-19.7
|
-22.6
|
-22.09
|
-24.19
|
Net income
1 |
-10.78
|
-12.9
|
-11.53
|
-12.84
|
-13.25
|
-13.6
|
-12.19
|
-12.6
|
-15.08
|
-14.31
|
-17.52
|
-19.25
|
-21.47
|
-22.09
|
-24.19
|
Net margin
|
-5,688.25%
|
-7,020.34%
|
-12,208.54%
|
-33,466.21%
|
-2,879,469.57%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0500
|
-0.4900
|
-0.4400
|
-0.4900
|
-0.5000
|
-0.5100
|
-0.4300
|
-0.4300
|
-0.5200
|
-0.4900
|
-0.5333
|
-0.5167
|
-0.5467
|
-0.5000
|
-0.4400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-03-10
|
22-05-10
|
22-08-10
|
22-11-10
|
23-03-06
|
23-05-04
|
23-08-03
|
23-11-09
|
24-03-01
|
24-05-07
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
149
|
101
|
80.9
|
57.8
|
72.8
|
105
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-50.2%
|
-38%
|
-53.4%
|
-84.5%
|
-105%
|
-91.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
11.50
|
4.160
|
3.090
|
2.020
|
1.880
|
2.030
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
0.34
|
0.3
|
0.3
|
0.3
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-05-13
|
22-03-10
|
23-03-06
|
24-03-01
|
-
|
-
|
-
|
Last Close Price
1.63
USD Average target price
15.14
USD Spread / Average Target +829.01% Consensus |
1st Jan change
|
Capi.
|
---|
| -78.78% | 48.33M | | +23.37% | 46.71B | | +48.83% | 41.8B | | -0.94% | 41.52B | | -5.86% | 29.55B | | +11.29% | 25.78B | | -20.92% | 19.26B | | +3.20% | 12.14B | | -2.67% | 12.08B | | +30.23% | 11.98B |
Other Biotechnology & Medical Research
|